微生物学
金黄色葡萄球菌
SCCmec公司
溶血
生物
葡萄球菌
万古霉素
琼脂稀释
替加环素
耐甲氧西林金黄色葡萄球菌
抗菌剂
细菌
最小抑制浓度
遗传学
免疫学
作者
Lu Wang,Jingrong Cao,Liyan Ye,Yueyun Shen,Kaisheng Lai,Dingxia Shen
标识
DOI:10.3760/cma.j.issn.1009-9158.2020.02.016
摘要
Objective
To investigate the characteristics of hemolysis, resistance and homology of Staphylococcus cohnii urealyticum.
Methods
A retrospective study was carried out on thirteen clinical strains of Staphylococcus cohnii urealyticum. They were re-identified by MALDI-TOF MS. Their colony and hemolytic characteristics on blood agar plates were observed. The co-hemolysis between Staphylococcus cohnii urealyticum and Staphylococcus aureus was demonstrated. The hemolysin genes and drug resistance genes were detected by PCR. Pulsed field gel electrophoresis and mass spectrometry were used to analyze the homology of strains. The susceptibility of strains to antimicrobial agents was detected by agar dilution.
Results
The confirmed 13 strains of Staphylococcus cohnii urealyticum showed various levels of hemolysis and had enhanced synergistic hemolysis with Staphylococcus aureus. All strains were susceptible to vancomycin and tigecycline. There were 12 strains which carried mecA gene, 7 strains carried cfr gene, 7 strains carried ermC gene. The 13 strains were divided into 3 groups by MALDI-TOF MS, and 6 types by pulsed field gel electrophoresis.
Conclusions
Clinical strains of Staphylococcus cohnii urealyticum demonstrated various levels of hemolysis which could be enhanced by Staphylococcus aureus. Although they carried different drug resistance genes, they were all susceptible to vancomycin and tigecycline.
Key words:
Staphylococcus; Drug resistance, bacterial; Sequence homology
科研通智能强力驱动
Strongly Powered by AbleSci AI